DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Planchard D, Besse B, Groen HJM. et al.
Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial.
Lancet Oncol 2016;
17: 984-993
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.